• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Duearity

Less than 1K followers
All
Research
Press releases
ShowingAll content types

Press release10.03.2024, 13.43

Duearity has entered into an agreement with a national distributor in the USA

Duearity
Press release06.02.2024, 08.53

Clinics in the US can now purchase Tinearity G1 through a national trading platform

Duearity
Eminova Partners day - Duearity
Video15.01.2024, 12.34 by
Lucas Mattsson, Jesper Hagman

Eminova Partners day - Duearity

During the day with Eminova Partners, analyst Lucas Mattsson got the chance to interview Fredrik Westman, CEO of Duearity. The discussion includes Duearity as an investment, what the market looks like today and what the strategy for Duearity looks like in the future.

Duearity

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release20.12.2023, 08.50

Duearity's sales SEK 450,000 in December - the best month so far

Duearity
Regulatory press release02.10.2023, 11.11

Duearity AB has signed a distributor agreement - covering Belgium, the Netherlands and Luxembourg

Duearity
Press release25.08.2023, 10.29

Duearity Americas Inc has signed agreements with the first clinics in the United States

Duearity
Regulatory press release27.07.2023, 10.22

Duearity AB has signed a distributor agreement in Great Britain

Duearity
Press release05.06.2023, 08.00

Positive results from Duearity's user study on people with tinnitus

Duearity
Regulatory press release23.05.2023, 11.01

Duearity AB has signed a distributor agreement

Duearity
Regulatory press release26.04.2023, 14.52

The tinnitus product Tinearity G1 has received market approval in the UK

Duearity
Regulatory press release31.10.2022, 08.27

Duearity will submit an application for approval of a tinnitus product in the United States

Duearity
Regulatory press release02.11.2021, 08.41

Duearity to develop AI solution for people suffering from tinnitus

Duearity